PARP1 also facilitates the recruitment of MGMT proteins for the repair of O6-methylguanine residues, and, hence, the overexpression of PARP1 and the decreased PARP1 cleavage are commonly associated with increased chemoresistance and poor survival in GBM patients [35]. This evidence concerns the gene MGMT and glioblastoma.